Lantheus Medical Imaging, Inc.
Bedford, MA Doing business as Lantheus Medical Imaging Inc. Lantheus Medical Imaging, Inc.
- UEI
- ZBTPKVDXCKJ7
- CAGE
- 1YCS9
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Lantheus Medical Imaging, Inc.
ZBTPKVDXCKJ7
- Evergreen Theragnostics, Inc. ZYKDF6W9MBD4
-
Lantheus Medical Imaging, Inc.
ZBTPKVDXCKJ7
- SAM.gov registration date
- Physical address
- 201 Burlington Rd, Bedford, MA 01730, USA
- Website
- lantheus.com
- Founded
- 1956
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Psma doses | Veterans Integrated Service Network 15 | $541,308 | |
| Pharmaceutical supplies for medical treatment facility | Defense Health Agency | $21,652 | |
| Acquisition of diagnostic and therapeutic products | Defense Health Agency | $248,340 | |
| Technelite generators MO99/TC99M and xenon 133 gas for bamc, JBSA fort SAM houston, TX. | Medical Command | $244,611 | |
| Radiopharmaceuticals | Medical Command | $77,206 |
About Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc., a subsidiary of Lantheus Holdings, Inc., is a for-profit manufacturer of diagnostic medical imaging agents and radiopharmaceutical products headquartered in North Billerica, Massachusetts. The company specializes in nuclear medicine technologies and supplies, including technetium-99m generators, radiopharmaceuticals, contrast media, and other specialized diagnostic imaging agents. As a critical supplier to federal healthcare agencies, Lantheus Medical Imaging has established itself as a primary provider of essential nuclear medicine products that support diagnostic imaging procedures across military treatment facilities, Department of Veterans Affairs medical centers, and other federal healthcare institutions. The company is registered in SAM.gov and maintains an active federal contracting status with a Unique Entity Identifier of ZBTPKVDXCKJ7.
Lantheus Medical Imaging, Inc. has provided an extensive range of radiopharmaceutical products and nuclear medicine supplies through multiple prime federal contract awards issued primarily by the Defense Health Agency, with additional awards from the Department of Veterans Affairs and the U.S. Army Medical Command. The company's product offerings include TechneLite MO99/TC99M generators in various configurations, Xenon-133 radiopharmaceuticals, PYLARIFY (piflufolastat F 18) injection, and other injectable diagnostic imaging agents. These products have supported medical imaging operations at numerous military treatment facilities including Dwight D. Eisenhower Army Medical Center in Fort Eisenhower, Georgia; Tripler Army Medical Center in Hawaii; Walter Reed National Military Medical Center; U.S. Naval Hospital Guam; and Memphis VA Medical Center. Contract awards have ranged from purchase orders and delivery orders to blanket purchase agreement calls, with individual awards ranging from approximately $9,000 to $796,499. The majority of Lantheus Medical Imaging's federal contracts have been awarded without small business set-aside designations, though the company has received a limited number of total small business set-aside contracts, including a $796,499.10 definitive contract for nuclear medicine pharmaceuticals and generators at Fort Eisenhower and a $19,321.68 purchase order for TC99M generators. Firm fixed-price contract terms have been standard across the company's federal contract portfolio.
Lantheus Medical Imaging, Inc. currently holds a single-award Blanket Purchase Agreement valued at $6.5 million with the Defense Health Agency, established against the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) with a period of performance extending through July 27, 2028. This IDV covers a comprehensive range of diagnostic nuclear imaging supplies and agents, including radiopharmaceuticals, contrast media, and other specialized nuclear medicine products required by federal healthcare agencies. The BPA has generated numerous task orders and delivery orders from the Defense Health Agency since its award in July 2023, enabling the agency to efficiently procure Lantheus' specialized medical imaging technologies and supplies on an as-needed basis. The company's GSA Schedule contract vehicles have proven instrumental in streamlining the federal procurement process, allowing multiple military treatment facilities and VA medical centers to access critical radiopharmaceutical products through established pricing and delivery mechanisms. Task orders issued against the BPA have addressed specific facility needs across the Defense Health Agency's network of military treatment facilities, supporting the agency's medical imaging and diagnostic capabilities throughout the contract period.
Contract vehicles
Quick answers
What is Lantheus Medical Imaging, Inc.'s UEI?
Lantheus Medical Imaging, Inc.'s Unique Entity ID (UEI) in SAM.gov is ZBTPKVDXCKJ7.
What is Lantheus Medical Imaging, Inc.'s CAGE code?
Lantheus Medical Imaging, Inc.'s CAGE code is 1YCS9.
What is Lantheus Medical Imaging, Inc.'s primary NAICS code?
Lantheus Medical Imaging, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Lantheus Medical Imaging, Inc. located?
Lantheus Medical Imaging, Inc.'s physical address in SAM.gov is 201 Burlington Rd, Bedford, MA 01730, USA.
Is Lantheus Medical Imaging, Inc. registered in SAM.gov?
Yes. Lantheus Medical Imaging, Inc.'s SAM.gov registration is active through December 17, 2026.
Which contract vehicles does Lantheus Medical Imaging, Inc. hold?
Lantheus Medical Imaging, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Lantheus Medical Imaging, Inc.'s most recent federal award?
Lantheus Medical Imaging, Inc.'s most recent federal contract award is Psma doses (36C25526F0111), from Veterans Integrated Service Network 15, on July 20, 2026.
On GovTribe
See Lantheus Medical Imaging, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors